Dennis (“Denny”) Van Liew, MS, FRSA is a global life-sciences advisor specializing in precision medicine, pharmacovigilance, and commercialization strategy. He brings more than 25 years of experience guiding biotech, diagnostics, and health-technology companies through scale-up, regulatory complexity, market access, and investor readiness.
Denny established The Pareto Group after retiring from Red Nucleus. As Principal, Denny serves as a strategic partner to CEOs and executive teams across Africa, MENA, Europe, and the US. His work spans organizational design, safety and regulatory operations, go-to-market strategy, and data-driven business models for next-generation precision-medicine platforms. He also holds board-level and senior-advisor roles with emerging companies in genomic testing, AI-enabled drug development, and PV outsourcing.
Deeply engaged in the global drug-safety community, Denny is a founding board member of the Personalized Medicine Coalition and serves on the Executive Committee of the North America Chapter of International Society of Pharmacovigilance (NASoP). Known for his ability to translate complex science into practical business strategy, he supports organizations seeking clarity, structure, and momentum in periods of rapid growth or transformation.
Veritux independent consultants are available where you need them – in all major markets and every global region.
